EXECUTIVE ENGAGEMENTS
POOL
3669
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
662
Interactions with Platform & by Email
PARTICIPANTS
112
Unique # Participated
VALIDATIONS
32
Responses Validated*
COMPANIES
29
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
188
EDITION
7
PRICE
USD 4950
CODE
MCP11646
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Global Drug Discovery Informatics Market to Reach $3.5 Billion by 2026
Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2026, growing at a CAGR of 9.8% over the analysis period. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $666.4 Million in 2021, While China is Forecast to Reach $608.2 Million by 2026
The Drug Discovery Informatics market in the U.S. is estimated at US$666.4 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$608.2 Million by the year 2026 trailing a CAGR of 9.1% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.
Molecular Modelling Segment to Reach US$723.7 Million by the year 2026
In the global Molecular Modelling segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$329.5 Million in the year 2020 will reach a projected size of US$657.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
Certara USA, Inc.; Charles River Laboratories International, Inc.; Collaborative Drug Discovery, Inc.; Dassault Systemes; GVK Biosciences Pvt., Ltd.; IBM Corporation; Infosys Ltd.; Jubilant Life Sciences Ltd.; Novo Informatics Pvt., Ltd.; Openeye Scientific Software; PerkinElmer, Inc.; Schrodinger LLC; Selvita SA; Thermo Fisher Scientific, Inc.
SEGMENTS
» End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), Other End-Uses) » Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation, Other Functions) » Solution (Software, Services)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Dwindling Government Funding Support for Healthcare R&D, A Major Challenge for Growth in the Country |
| USA Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| USA Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| USA Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| I. METHODOLOGY |
| CANADA |
| Canada Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Drug Discovery Informatics: A Prelude |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market |
| Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019 |
| Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market |
| Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics |
| Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics |
| The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine |
| Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Cloud Computing Emerges to Play a Key Role in Bioinformatics |
| Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics |
| Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024 |
| Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics |
| Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025 |
| Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics |
| Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics |
| Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations (CROS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Contract Research Organizations (CROS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 29 |
| CHINA |
| China Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| China Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| China Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Drug Discovery Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| France Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| France Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| UK Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| UK Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com